跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,430 条关于
“Numotion”
全部
1,430
临床试验
1,403
药物
1
机构
5
资讯
21
去年
Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton
去年
Nuvation Bio Surges 14.9% on Analyst Upgrades and Oncology Pipeline Progress
去年
Nuvation Bio Secures $250M Financing for US Launch of ROS1 Inhibitor Taletrectinib
3个月前
Nuvation Bio Director Buys 25,000 Shares as Taletrectinib Gains Global Regulatory Momentum
去年
Nuvation Bio Secures $250M Financing Package to Launch Novel Lung Cancer Drug Taletrectinib
去年
Nuvation Bio's Taletrectinib Gains FDA Priority Review and Expanded Access Program for ROS1+ NSCLC
2年前
Taletrectinib Shows Promise in ROS1-Positive NSCLC: Nuvation Bio Announces Positive Phase 2 Data
2个月前
Nuvation Bio's David Hung on Building a Pipeline of Best-in-Class Oncology Drugs
8个月前
Nuvation Bio's IBTROZI Demonstrates Strong Commercial Performance with 432 New Patients in First Six Months
12年前
Time and Motion Studies Emerge as Critical Tool for Healthcare Efficiency Assessment
第 1 页,共 3 页
上一页
下一页